Heartflow, Inc.

Public Equity (NASDAQ)AIHealthcareMedTech

📍 Mountain View, CA, USA

StreetZero Signal 58

Be the first to signal interest

About Heartflow, Inc.

Heartflow, Inc. is a leader in AI technology for coronary artery disease (CAD). It provides AI-powered medical technology that models patient-specific blood flow using FFRCT analysis. The company enhanced its platform with a cloud-based infrastructure in 2018 to enable faster data transfer and integrate machine learning from global clinical data.

LATEST FUNDINGRule 144

$311K

Announced 2026-10-22

TOTAL RAISED$364.2M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Heartflow, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQMountain View, CA, USA

Industry

Public Equity (NASDAQ)

Investors

Bain Capital

Key highlights

Heartflow priced an upsized IPO of nearly 19.2 million shares at $19 each.
Bain Capital-backed company debuted on Nasdaq under ticker HTFL in August 2025.
IPO generated approximately $364.2 million in gross proceeds.
Company focuses on AI analysis for coronary artery disease using FFRCT technology.
Early NSF funding supported foundational research on blood flow modeling.